Cargando…
In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials
PURPOSE: To test a reduced version—CIPN15—of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy scale (QLQ-CIPN20) to establish a possible gold-standard patient-reported outcome measure for chemotherapy-indu...
Autores principales: | Smith, Ellen M. Lavoie, Knoerl, Robert, Yang, James J., Kanzawa-Lee, Grace, Lee, Deborah, Bridges, Celia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925747/ https://www.ncbi.nlm.nih.gov/pubmed/29480026 http://dx.doi.org/10.1177/1073274818756608 |
Ejemplares similares
-
Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
por: Lee, Deborah, et al.
Publicado: (2019) -
What do the data say about chemotherapy-induced peripheral neuropathy assessment and management?
por: Kanzawa-Lee, Grace, et al.
Publicado: (2022) -
Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
por: Knoerl, Robert, et al.
Publicado: (2021) -
Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis
por: Knoerl, Robert, et al.
Publicado: (2022) -
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017)